In adaptive immunity, KLF4 inhibits the proliferation of CD8+ T cells and B cells through transcriptional repression of pro-survival and cell cycle-promoting genes such as NOTCH1 while also acting as a tumor suppressor. This evidence concerns the gene KLF4 and neoplasm.